239 related articles for article (PubMed ID: 30608986)
21. A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies.
Wong AW; Koo J; Ryerson CJ; Sadatsafavi M; Chen W
BMC Pulm Med; 2022 Apr; 22(1):148. PubMed ID: 35443657
[TBL] [Abstract][Full Text] [Related]
22. Costs and economic evaluations of Quality Improvement Collaboratives in healthcare: a systematic review.
de la Perrelle L; Radisic G; Cations M; Kaambwa B; Barbery G; Laver K
BMC Health Serv Res; 2020 Mar; 20(1):155. PubMed ID: 32122378
[TBL] [Abstract][Full Text] [Related]
23. Cost-of-illness and Economic Evaluation of Interventions in Children and Adolescents With Chronic Pain: A Systematic Review.
Kitschen A; Wahidie D; Meyer D; Rau LM; Ruhe AK; Wager J; Zernikow B; Sauerland D
Clin J Pain; 2024 May; 40(5):306-319. PubMed ID: 38268231
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and cost of Lyme disease-related hospitalizations among patients with employer-sponsored health insurance-United States, 2005-2014.
Schwartz AM; Shankar MB; Kugeler KJ; Max RJ; Hinckley AF; Meltzer MI; Nelson CA
Zoonoses Public Health; 2020 Jun; 67(4):407-415. PubMed ID: 32462811
[TBL] [Abstract][Full Text] [Related]
25. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.
Rodgers M; Asaria M; Walker S; McMillan D; Lucock M; Harden M; Palmer S; Eastwood A
Health Technol Assess; 2012 May; 16(28):1-130. PubMed ID: 22642789
[TBL] [Abstract][Full Text] [Related]
26. Lyme disease--what is the cost for Scotland?
Joss AW; Davidson MM; Ho-Yen DO; Ludbrook A
Public Health; 2003 Jul; 117(4):264-73. PubMed ID: 12966749
[TBL] [Abstract][Full Text] [Related]
27. Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
Wu CH; Kao IJ; Hung WC; Lin SC; Liu HC; Hsieh MH; Bagga S; Achra M; Cheng TT; Yang RS
Osteoporos Int; 2018 Jun; 29(6):1227-1242. PubMed ID: 29460102
[TBL] [Abstract][Full Text] [Related]
28. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
Elife; 2023 Aug; 12():. PubMed ID: 37534878
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and costs of dengue in Thailand: A systematic literature review.
Thisyakorn U; Saokaew S; Gallagher E; Kastner R; Sruamsiri R; Oliver L; Hanley R
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010966. PubMed ID: 36534668
[TBL] [Abstract][Full Text] [Related]
30. Lyme borreliosis in Belgium: a cost-of-illness analysis.
Geebelen L; Devleesschauwer B; Lernout T; Tersago K; Parmentier Y; Van Oyen H; Speybroeck N; Beutels P
BMC Public Health; 2022 Nov; 22(1):2194. PubMed ID: 36443755
[TBL] [Abstract][Full Text] [Related]
31. Cost of delivering secondary-level health care services through public sector district hospitals in India.
Prinja S; Balasubramanian D; Jeet G; Verma R; Kumar D; Bahuguna P; Kaur M; Kumar R
Indian J Med Res; 2017 Sep; 146(3):354-361. PubMed ID: 29355142
[TBL] [Abstract][Full Text] [Related]
32. The cost of Lyme borreliosis.
van den Wijngaard CC; Hofhuis A; Wong A; Harms MG; de Wit GA; Lugnér AK; Suijkerbuijk AWM; Mangen MJ; van Pelt W
Eur J Public Health; 2017 Jun; 27(3):538-547. PubMed ID: 28444236
[TBL] [Abstract][Full Text] [Related]
33. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
Anopa Y; Conway DI
Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
[TBL] [Abstract][Full Text] [Related]
34. What Is the Financial Impact of Orthopaedic Sequelae of Intravenous Drug Use on Urban Tertiary-care Centers?
Dwivedi N; Breslin MA; McDermott A; Lin S; Vallier HA; Tornetta P
Clin Orthop Relat Res; 2020 Oct; 478(10):2202-2212. PubMed ID: 32667752
[TBL] [Abstract][Full Text] [Related]
35. The cost effectiveness of vaccinating against Lyme disease.
Meltzer MI; Dennis DT; Orloski KA
Emerg Infect Dis; 1999; 5(3):321-8. PubMed ID: 10341168
[TBL] [Abstract][Full Text] [Related]
36. Global systematic review of cost of illness and economic evaluation studies associated with snakebite.
Patikorn C; Leelavanich D; Ismail AK; Othman I; Taychakhoonavudh S; Chaiyakunapruk N
J Glob Health; 2020 Dec; 10(2):020415. PubMed ID: 33312499
[TBL] [Abstract][Full Text] [Related]
37. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
38. Economic impact of Lyme disease.
Zhang X; Meltzer MI; Peña CA; Hopkins AB; Wroth L; Fix AD
Emerg Infect Dis; 2006 Apr; 12(4):653-60. PubMed ID: 16704815
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
